These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 4075371)

  • 1. Acetylcholinesterase fluctuations in the brain of mice during morphine dependence development, withdrawal and naloxone induced withdrawal.
    Sood PP; Mohanakumar KP
    Cell Mol Biol; 1985; 31(6):475-88. PubMed ID: 4075371
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of acid and alkaline phosphatases in the central nervous system of mice during morphine dependence development, withdrawal and naloxone administration.
    Sood PP; Mohanakumar KP
    Cell Mol Biol; 1985; 31(6):469-73. PubMed ID: 4075370
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in ribonuclease in the central nervous system of mice during morphine dependence development, withdrawal and naloxone administration.
    Mohanakumar KP; Sood PP
    Clin Physiol Biochem; 1986; 4(2):159-63. PubMed ID: 2421960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluctuations of acetylcholinesterase in the mouse spinal cord and in vivo sodium effect during the development of morphine tolerance, dependence, and withdrawal.
    Mohanakumar KP; Sood PP
    Neurochem Res; 1986 Apr; 11(4):505-20. PubMed ID: 3724959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in succinic dehydrogenase activity in the central nervous system of mice during morphine dependence development, withdrawal and naloxone treatment.
    Sood PP; Mohanakumar KP
    Clin Physiol Biochem; 1985; 3(4):193-8. PubMed ID: 4040449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory action of morphine on adenosine triphosphatase content in the whole and individual nuclei of mouse brain during the tolerance-dependence development and its reversal by naloxone.
    Mohanakumar KP; Sood PP
    J Hirnforsch; 1985; 26(6):695-708. PubMed ID: 3005393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural and chemical changes in mice during morphine dependence development, withdrawal and naloxone administration.
    Mohanakumar KP; Sood PP
    Cell Mol Biol; 1985; 31(6):463-8. PubMed ID: 2416443
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of cyclic AMP-specific phosphodiesterase 4 activation during naloxone-precipitated morphine withdrawal in rats.
    Kimura M; Tokumura M; Itoh T; Inoue O; Abe K
    Neurosci Lett; 2006 Aug; 404(1-2):107-11. PubMed ID: 16753260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism by naloxone of morphine-induced single-dose dependence and antinociception in mice.
    Smits SE
    Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):689-96. PubMed ID: 12548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluctuations of succinic dehydrogenase during morphine tolerance, dependence and withdrawals in the spinal cord and medulla oblongata of mice.
    Josephjohn K; Sood PP
    Acta Neurol Belg; 1988; 88(5):281-9. PubMed ID: 3252685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Different roles of the spinal protein kinase C alpha and gamma in morphine dependence and naloxone-precipitated withdrawal].
    Cao JL; Ding HL; He JH; Zhang LC; Wang JK; Zeng YM
    Sheng Li Xue Bao; 2005 Apr; 57(2):161-8. PubMed ID: 15830100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between inhibitions of morphine withdrawal and nitric-oxide synthase by agmatine.
    Li J; Li X; Pei G; Qin BY
    Zhongguo Yao Li Xue Bao; 1999 Apr; 20(4):375-80. PubMed ID: 10452129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The physical dependence liabilities of oxybutynin and morphine in rats.
    Algate DR; Beard DJ
    Arzneimittelforschung; 1985; 35(10):1577-9. PubMed ID: 4074417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activation of the spinal extracellular signal-regulated kinase is involved in morphine dependence and naloxone-precipitated withdrawal response].
    He JH; Cao JL; Xu YB; Song XS; Ding HL; Zeng YM
    Sheng Li Xue Bao; 2005 Oct; 57(5):557-65. PubMed ID: 16220193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice.
    Li T; Hou Y; Cao W; Yan CX; Chen T; Li SB
    Neurosci Lett; 2010 Jan; 468(3):348-52. PubMed ID: 19922770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective mGlu5 receptor antagonist MTEP attenuates naloxone-induced morphine withdrawal symptoms.
    Pałucha A; Brański P; Pilc A
    Pol J Pharmacol; 2004; 56(6):863-6. PubMed ID: 15662102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence.
    Liu J; Schulteis G
    Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcholinesterase changes in the central nervous system of mice during the development of morphine tolerance addiction and withdrawal.
    Mohanakumar KP; Sood PP
    Brain Res Bull; 1983 May; 10(5):589-96. PubMed ID: 6683583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acute and continuous morphine administration on catecholamine-sensitive adenosine triphosphatase in mouse brain.
    Desaiah D; Ho IK
    J Pharmacol Exp Ther; 1979 Jan; 208(1):80-5. PubMed ID: 215749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.